These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23270556)

  • 1. Modulation of individual susceptibility to the no-reflow phenomenon after acute myocardial infarction.
    Iwakura K
    Curr Pharm Des; 2013; 19(25):4519-28. PubMed ID: 23270556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for development of the no-reflow phenomenon in patients with reperfused anterior wall acute myocardial infarction.
    Iwakura K; Ito H; Kawano S; Shintani Y; Yamamoto K; Kato A; Ikushima M; Tanaka K; Kitakaze M; Hori M; Higashino Y; Fujii K
    J Am Coll Cardiol; 2001 Aug; 38(2):472-7. PubMed ID: 11499740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological prevention of reperfusion injury in acute myocardial infarction. A potential role for adenosine as a therapeutic agent.
    Quintana M; Kahan T; Hjemdahl P
    Am J Cardiovasc Drugs; 2004; 4(3):159-67. PubMed ID: 15134468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive factors of myocardial reperfusion in patients with anterior wall acute myocardial infarction.
    Olszowska M; Tracz W; Kostkiewicz M; Podolec P
    Cardiol J; 2008; 15(1):57-62. PubMed ID: 18651386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
    Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
    JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiographic morphologic features of infarct-related arteries and timely reperfusion in acute myocardial infarction: predictors of slow-flow and no-reflow phenomenon.
    Yip HK; Chen MC; Chang HW; Hang CL; Hsieh YK; Fang CY; Wu CJ
    Chest; 2002 Oct; 122(4):1322-32. PubMed ID: 12377860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The "no reflow" phenomenon following acute myocardial infarction: mechanisms and treatment options.
    Kaul S
    J Cardiol; 2014 Aug; 64(2):77-85. PubMed ID: 24799155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial no-reflow in humans.
    Niccoli G; Burzotta F; Galiuto L; Crea F
    J Am Coll Cardiol; 2009 Jul; 54(4):281-92. PubMed ID: 19608025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Beneficial effects of nicorandil on myocardial no-reflow state in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jul; 17(7):421-5. PubMed ID: 16004786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration.
    Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous coronary intervention and the no-reflow phenomenon.
    van Gaal WJ; Banning AP
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of spatial patterns of flow within the reperfused myocardium by myocardial contrast echocardiography. Implications in determining extent of myocardial salvage.
    Villanueva FS; Glasheen WP; Sklenar J; Kaul S
    Circulation; 1993 Dec; 88(6):2596-606. PubMed ID: 8252670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction.
    Aung Naing K; Li L; Su Q; Wu T
    Cochrane Database Syst Rev; 2013 Jun; (6):CD009503. PubMed ID: 23736949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial 'no-reflow' prevention.
    Magro M; Springeling T; van Geuns RJ; Zijlstra F
    Curr Vasc Pharmacol; 2013 Mar; 11(2):263-77. PubMed ID: 23506503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of single-dose atorvastatin on interleukin-6, interferon gamma, and myocardial no-reflow in a rabbit model of acute myocardial infarction and reperfusion.
    Zhao XJ; Liu XL; He GX; Xu HP
    Braz J Med Biol Res; 2014 Feb; 47(3):245-51. PubMed ID: 24554037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of the no-reflow phenomenon with ultrasonic tissue characterization in patients with anterior wall acute myocardial infarction.
    Iwakura K; Ito H; Kawano S; Okamura A; Tanaka K; Nishida Y; Maekawa Y; Masuyama T; Hori M; Fujii K
    Am J Cardiol; 2004 Jun; 93(11):1357-61, A5. PubMed ID: 15165914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Beneficial effects of ischemic preconditioning on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
    Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):486-90. PubMed ID: 16178445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of nicorandil treatment adjunctive to percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis.
    Zhou J; Xu J; Cheng A; Li P; Chen B; Sun S
    J Int Med Res; 2020 Nov; 48(11):300060520967856. PubMed ID: 33249959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.